gebhart/patrepeval huggingface dataset:
Long-term outcomes after endoscopic ultrasound-guided ablation of pancreatic cysts (2017)

<b>Background and study aims</b> The aim of this study was to investigate the long-term outcomes after endoscopic ultrasound (EUS)-guided pancreatic cyst ablation. <b>Patients and methods</b> In a single-center, prospective study, 164 patients with pancreatic cysts underwent EUS-guided cyst ablation using ethanol with paclitaxel. The inclusion criteria were as follows: unilocular or oligolocular cysts; clinically indeterminate cysts that required EUS fine-needle aspiration; and/or cysts that grew during the observation period. Treatment response was classified as complete resolution, partial resolution, or persistent cyst, with < 5 %, 5 % - 25 %, and 25 % of the original cyst volume, respectively. <b>Results</b> The median largest diameter of the cyst was 32 mm and the median volume was 17.1 mL. Based on cyst fluid analysis there were 71 mucinous cystic neoplasms, 16 serous cystic neoplasms, 11 intraductal papillary mucinous neoplasms, 3 pseudocysts, and 63 indeterminate cysts. Sixteen treated patients (9.8 %) had adverse events (1 severe, 4 moderate, and 11 mild). Treatment response was as follows: complete resolution in 114 (72.2 %), partial resolution in 31 (19.6 %), and persistent cysts in 13 (8.2 %). Twelve of the 13 patients with persistent cysts underwent surgery. During clinical and imaging follow-up (median 72 months, interquartile range 50 - 85 months) of the 114 patients with complete resolution, only two patients (1.7 %) showed cyst recurrence. Based on multivariate analysis, the absence of septa (odds ratio [OR] 7.12, 95 % confidence interval [CI] 2.72 - 18.67) and cyst size less than 35 mm (OR 2.39, 95 %CI 1.11 - 5.16) predicted complete resolution. <b>Conclusion</b> Among patients with pancreatic cysts in whom complete resolution was achieved after EUS-guided cyst ablation, 98.3 % remained in remission at 6-year follow-up. Unilocular form and small cyst size were predictive of complete resolution. This treatment approach may be an effective and durable alternative to surgery.Trial registered at ClinicalTrials.gov (NCT 00689715).
Neuropeptide Y Y2 receptor in health and disease (2007)

We briefly survey the current knowledge and concepts regarding structure and function of the neuropeptide Y Y2 receptor and its agonists, especially as related to pharmacology of the receptor and its roles in pathological processes. Specific structural features are considered that could be responsible for the known compartmentalization and participation of the receptor in cell and tissue organization. This is further discussed in relation to changes of levels of the Y2 receptor in pathological conditions (especially in epilepsy and drug abuse), to endocytosis and recycling, and to participation in wound healing, retinopathy and angiogenesis. Properties of the receptor and of Y2 agonists are considered and reviewed in connection to the negative regulation of transmitter release, feeding, mood and social behavior. The possible involvement of the Y2 receptor in diabetes, carcinogenesis and bone formation is also reviewed.
Translucent A1N Ceramic Substrate (1986)

A translucent aluminum nitride (AlN) substrate has recently come into the market which has a thermal conductivity of 140 W/mK at room temperature and 130 W/mK at 100°C, eight times that of alumina (Al <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</inf> O <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">3</inf> ) and one-half to two-thirds that of beryllia (BeO). Its excellent electrical and mechanical properties as well as inherent light transmitting property ensure that the new AlN material can be used as high-performance ceramic substrates for high-power and high-speed semiconductor modules. Metallization of the ceramic has been done by three methods: 1) tungsten metallization by a co-firing process, which is a fundamental technology for the coming multilayer AlN packages; 2) metallization with silver-palladium (Ag/Pd) conductor and ruthenium-oxide (RuO <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</inf> ) resistor, which was developed for the translucent AlN substrate; and 3) molten metal metallization, which gives very high adhesive strength. Development of an improved AlN ceramic with a thermal conductivity exceeding that of BeO is also described.
Evolution of the Neurochemical Profile after Transient Focal Cerebral Ischemia in the Mouse Brain (2009)

Evolution of the neurochemical profile consisting of 19 metabolites after 30 mins of middle cerebral artery occlusion was longitudinally assessed at 3, 8 and 24 h in 6 to 8 microL volumes in the striatum using localized 1H-magnetic resonance spectroscopy at 14.1 T. Profound changes were detected as early as 3 h after ischemia, which include elevated lactate levels in the presence of significant glucose concentrations, decreases in glutamate and a transient twofold glutamine increase, likely to be linked to the excitotoxic release of glutamate and conversion into glial glutamine. Interestingly, decreases in N-acetyl-aspartate (NAA), as well as in taurine, exceeded those in neuronal glutamate, suggesting that the putative neuronal marker NAA is rather a sensitive marker of neuronal viability. With further ischemia evolution, additional, more profound concentration decreases were detected, reflecting a disruption of cellular functions. We conclude that early changes in markers of energy metabolism, glutamate excitotoxicity and neuronal viability can be detected with high precision non-invasively in mice after stroke. Such investigations should lead to a better understanding and insight into the sequential early changes in the brain parenchyma after ischemia, which could be used for identifying new targets for neuroprotection.
Influence of Preparation Factors on Ca/P Ratio and Surface Basicity of Hydroxyapatite Catalyst (2009)

We aimed at precision control of the basicity of hydroxyapatite (Ca10(PO4)6(OH)2; HAP) and paid attention to four key factors in the synthesizing process—the solution's Ca/P ratio, pH, temperature and stirring time—and compared their influence on the Ca/P ratio and basicity of HAP. Among them, solution pH had the greatest influence on Ca/P ratio within the bulk of the catalyst. This was followed in order of influence by the Ca/P ratio of the solution (the ratio of raw materials), solution temperature and stirring time. In addition, we found that samples of HAP with the same Ca/P ratio had almost the same basic site density, even if they were synthesized using different combinations of preparation factors. This indicates that the basic site density of HAP prepared by the precipitation method depends only on the Ca/P ratio within the bulk of the catalyst.
Potent In Vitro Antifungal Activities of Naturally Occurring Acetylenic Acids (2008)

Our continuing effort in antifungal natural product discovery has led to the identification of five 6-acetylenic acids with chain lengths from C(16) to C(20): 6-hexadecynoic acid (compound 1), 6-heptadecynoic acid (compound 2), 6-octadecynoic acid (compound 3), 6-nonadecynoic acid (compound 4), and 6-icosynoic acid (compound 5) from the plant Sommera sabiceoides. Compounds 2 and 5 represent newly isolated fatty acids. The five acetylenic acids were evaluated for their in vitro antifungal activities against Candida albicans, Candida glabrata, Candida krusei, Candida tropicalis, Candida parapsilosis, Cryptococcus neoformans, Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger, Trichophyton mentagrophytes, and Trichophyton rubrum by comparison with the positive control drugs amphotericin B, fluconazole, ketoconazole, caspofungin, terbinafine, and undecylenic acid. The compounds showed various degrees of antifungal activity against the 21 tested strains. Compound 4 was the most active, in particular against the dermatophytes T. mentagrophytes and T. rubrum and the opportunistic pathogens C. albicans and A. fumigatus, with MICs comparable to several control drugs. Inclusion of two commercially available acetylenic acids, 9-octadecynoic acid (compound 6) and 5,8,11,14-eicosatetraynoic acid (compound 7), in the in vitro antifungal testing further demonstrated that the antifungal activities of the acetylenic acids were associated with their chain lengths and positional triple bonds. In vitro toxicity testing against mammalian cell lines indicated that compounds 1 to 5 were not toxic at concentrations up to 32 muM. Furthermore, compounds 3 and 4 did not produce obvious toxic effects in mice at a dose of 34 mumol/kg of body weight when administered intraperitoneally. Taking into account the low in vitro and in vivo toxicities and significant antifungal potencies, these 6-acetylenic acids may be excellent leads for further preclinical studies.
Induction ofN-Hydroxycinnamoyltyramine Synthesis and TyramineN-Hydroxycinnamoyltransferase (THT) Activity by Wounding in Maize Leaves (2000)

Both N-p-coumaroyl- and N-feruloyltyramine accumulated in response to wounding in leaf segments of maize. The amount of N-hydroxycinnamoyltyramines started to increase 3-6 h after wounding and peaked at 12 h. Thereafter, the amount of N-p-coumaroyltyramine decreased rapidly, while the N-feruloyltyramine content remained at a high level. The accumulation of N-hydroxycinnamoyltyramines was accompanied by an increase in the tyramine N-hydroxycinnamoyltransferase (THT) activity. This increase was initially detected 3 h after wounding and reached a maximum at 36 h, the level of activity being 40 and 11 times that in the leaves before wounding and in the control leaves, respectively. Partial purification of THT from wounded leaves by (NH4)2SO4 precipitation and subsequent two steps of anion-exchange chromatography resulted in a 12.5-fold increase in specific activity. Kinetic studies with this partially purified enzyme revealed that the best substrates were tyramine and feruloyl-CoA, although tryptamine and sinapoyl-CoA also efficiently served as substrates. The apparent native molecular weight of the enzyme was determined by gel filtration as 40 kDa.
Particle trapping and self-focusing in temporally asymmetric ratchets with strong field gradients (1997)

We study the dynamics of a particle whose velocity is a nonlinear, monotonically increasing function of the applied field. The particle moves in a strong field gradient whose intensity and sign vary periodically. We demonstrate that if the field pulses are temporally asymmetric and biased, we can have situations where the particle always migrates towards a stable zero-velocity point. This special ratchet process can in principle be used to separate molecules and particles. An example is given for the electrophoresis of DNA.
Intravenous Anesthetics Differentially Modulate Ligand-gated Ion Channels (2000)

The alpha4beta4 nAChR, which is predominantly found in the central nervous system (CNS), is differentially affected by clinically relevant concentrations of intravenous anesthetics. Ketamine, commonly known to be an inhibitor at the N-methyl-D-aspartate receptor, is also a potent inhibitor at a central nAChR. It has little effect on a common CNS GABAA receptor in a clinically relevant concentration range. Interaction between ketamine and specific subtypes of nAChRs in the CNS may result in anesthetic behaviors such as inattention to surgical stimulus and in analgesia. Thiopental causes minor inhibition at the alpha4beta4 nAChR. Modulation of the alpha4beta4 nAChR by etomidate is unlikely to be important in anesthesia practice based on the insensitivity of this receptor to clinically used concentrations.
Nanocomposites Prepared by Threading Polymer Chains through Zeolites, Mesoporous Silica, or Silica Nanotubes (1996)

The purpose of this brief review is to describe some recent, preliminary attempts to prepare nanocomposites in which polymer chains thread through the cavities or channels of several types of inorganic materials, specifically zeolites, a mesoporous hexagonal form of silica, and silica nanotubes. One goal is to determine the effects of the constraining geometry on the properties of the chains, in particular, their glass transition temperatures. Another is the hope that this molecular threading will provide such intimate interactions between the polymer chains and their inorganic environment that novel reinforcement effects will be obtained.
Serodiagnosis of Early Lyme Disease: Analysis of IgM and IgG Antibody Responses by Using an Antibody-Capture Enzyme Immunoassay (1988)

We used an antibody-capture enzyme immunoassay (EIA) to evaluate the early antibody responses to Borrelia burgdorferi in paired sera from 30 patients with erythema chronicum migrans. During acute disease, 20 (67%) patients had elevated specific IgM responses, and by convalescence (one to four weeks after treatment), 28 (93%) patients had increased IgM or IgG responses. In acute specimens, elevated IgM responses correlated with disseminated infection; however, by convalescence, most patients with either localized or disseminated disease had positive tests. Among 133 control subjects, IgM cross-reactivity was observed in 4 of 37 patients with either Epstein-Barr virus or rickettsial infections, and false-positive IgG tests were seen in 8 of 28 patients with syphilis. With antibody-capture EIA, the diagnosis of Lyme disease can be confirmed in the majority of acutely ill patients and in almost all patients by convalescence.
Preparation and Properties of tert‐Butyloxycarbonylaminoacyl‐4‐(oxymethyl) phenylacetamidomethyl‐(Kel F‐g‐styrene) Resin, an Insoluble, Noncrosslinked Support for Solid Phase Peptide Synthesis (1978)

Abstract The Boc‐aminoacyl‐OCH 2 ‐Pam‐ derivative of Kel F‐g‐styrene resin has been synthesized by a chemically unambiguous route. Direct amidoalkylation of the unsubstituted resin followed by hydrazinolysis gave the aminomethyl‐resin. The loaded resin was obtained by reaction with a Boc‐aminoacyl‐OCH 2 ‐phenylacetic acid and DCC. The stability of this resin derivative towards acidolysis in trifluoroacetic acid was determined. Only 0.01–0.02 mol% loss of chains will occur in a single deprotection cycle in solid phase peptide synthesis. The peptidyl‐ and aminoacyl‐OCH 2 ‐Pam‐(Kel F‐g‐styrene) resins were cleaved with anhydrous HF‐anisole at 0°C in near‐quantitative yield. Simultaneous syntheses of the model peptide Leu‐Ala‐Gly‐Val on this resin and on Val‐OCH 2 ‐Pam‐poly(styrene‐ co ‐1% divinylbenzene) resin gave the same low levels of byproducts. No (&lt;0.1%) intersite aminolysis was observed on treatment of Leu‐Ala‐Gly‐Val‐OCH&lt; 2 ‐Pam‐(Kel F‐g‐styrene) resin with 5% diisopropylethylamine in dichloromethane for 22 h.
Allotypic differences in murine μ genes (1986)

We report the complete DNA sequence of a c-DNA clone of the heavy chain mu b allele of the C57BL/6 mouse. Comparisons have been made with the nucleotide sequences of the germ line BALB/c mu a and the plasmacytoma TEPC-183 mu a alleles reported elsewhere over the entire length of the coding and the 3' untranslated region. In contrast to the extensive differences between the gamma 2a a and b alleles we have reported earlier we see a very high degree of homology between the mu alleles. Only one of the nucleotide differences between C57BL/6 mu b and BALB/c mu a leads to an amino acid substitution. This single amino acid exchange must form the allotypic determinant of the mu b allele. A comparison of four different DNA sequences indicates that they are all distinct IgM alleles.
Affinity labeling of rat liver and kidney type I 5'-deiodinase. Identification of the 27-kDa substrate binding subunit. (1990)

Extrathyroidal production of 3,3',5-triiodothyronine from the thyroid secretory product, thyroxine, is catalyzed by tissue-specific iodothyronine 5'-deiodinases. Type I 5'-deiodinase (5'D-I) produces greater than 75% of the T3 found in the circulation and in thyroid hormone-responsive tissues and is most abundant in rat liver and kidney. In this study, we used the bromoacetyl derivatives of T4 (N-bromoacetyl-[125I]L-thyroxine, BrAcT4) and T3 (N-bromoacetyl-[125I]3,3',5-triiodothyronine, BrAcT3) as alkylating affinity labels to identify 5'D-I-related protein(s). BrAcT4 and BrAcT3 rapidly and irreversibly inactivated 5'D-I activity in liver and kidney microsomes. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of affinity labeled 5'D-I preparations showed that approximately 80% of the affinity label was incorporated into a protein with a Mr of 27,000 (p27). 5'D-I substrates and inhibitors specifically blocked affinity labeling of p27 with a rank order of potency (BrAcT4 greater than BrAcT3 greater than 3,5,3'-triiodothyronine (rT3) approximately flavone EMD 21388 greater than iodoacetate greater than N-acetyl-T4 (NAcT4) greater than N-acetyl-T3 (NAcT3] identical to that determined for inhibition of 5'-deiodination. Hyper- and hypothyroidism-induced increases and decreases in 5'D-I activity, respectively, were matched by comparable changes in the quantity of affinity labeled p27. BrAcT3 was a less effective affinity label for p27 and minor labeling of a new band with 53 kDa was observed. Molecular sieve chromatography of detergent-solubilized 5'D-I showed coincident peaks of p27 and 5'-deiodinating activity with an apparent Mr approximately 51,000. Two-dimensional gel electrophoresis showed that p27 was a single polypeptide with a pI of 6.1. Approximately 2-5 pmol of p27 were present per mg of liver microsomal protein, equal to previous estimates for 5'D-I content. Our results suggest that p27 represents the substrate binding subunit of type I 5'-deiodinase, the enzyme catalyzing the key reaction in the activation of T4 to the thyromimetically active T3.
Molecular Breeding to Enhance Ethanol Production from Corn and Sorghum Stover (2007)

ABSTRACT Political and environmental concerns have resulted in a growing interest in renewable energy, especially transportation fuels. In the United States the majority of fuel ethanol is currently produced from corn ( Zea mays L.) starch, but grain supplies will be insufficient to meet anticipated demands. Enzymatic hydrolysis of lignocellulosic biomass such as corn and sorghum [ Sorghum bicolor (L.) Moench] stover can provide an abundant alternative source of fermentable sugars. While production of cellulosic ethanol from stover is feasible from an energy‐balance perspective, its production is currently not economically competitive. Along with improvements in bioprocessing, enhancing the yield and composition of the biomass has the potential to make ethanol production considerably more cost effective. This requires (i) a better understanding of how cell wall composition and structure affect the efficiency of enzymatic hydrolysis, (ii) the development of traits that enhance biomass conversion efficiency and increase biomass yield, and (iii) the development of rapid screening protocols to evaluate biomass conversion efficiency. Several genetic resources are available to improve maize and sorghum as sources of lignocellulosic biomass. This includes the use of existing mutants, forward and reverse genetics to obtain novel mutants, and transgenic approaches in which the expression of genes of interest is modified. Plant breeding can be implemented to improve biomass yield, biomass quality, and biomass conversion efficiency, either through selection among progeny obtained by crossing parents with desirable traits, or as a way to enhance the agronomic performance of promising mutants and transgenics. Examples from current research will be used to illustrate progress in these different areas.
Therapeutic effects of ranibizumab in neovascular age-related macular degeneration (2007)

Vision loss due to age-related macular degeneration (AMD) is a major public health issue that significantly impacts the quality of life of affected individuals and their families. Recently approved anti-VEGF agents have shown promise as treatment options for the neovascular form of AMD. At present, ranibizumab is the most promising US FDA-approved treatment for neovascular AMD, with noteworthy effects on vision improvement and stabilization. The safety and efficacy of ranibizumab for the treatment of neovascular AMD were established in several pivotal clinical trials, including the Minimally Classic/Occult Trial of the Anti-VEGF Antibody Ranibizumab in the Treatment of Neovascular Age-Related Macular Degeneration (MARINA), and Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) trials. Ranibizumab is being further investigated as a potential therapy for other indications, including diabetic macular edema, retinal vein occlusion and presumed ocular histoplasmosis syndrome.
Pharmacological characterization of 5‐hydroxytryptamine‐induced contraction in the chicken gastrointestinal tract (2006)

5-Hydroxytryptamine (5-HT) receptor subtypes involved in 5-HT-induced contraction of the chicken gastrointestinal tract were characterized pharmacologically using subtype-selective agonists and antagonists. The proventriculus (area of stomach adjacent to the oesophagus) and ileum are examined. 5-HT applied cumulatively caused sustained contraction of the proventriculus that was not decreased by tetrodotoxin, atropine or l-nitro-arginine methylester (l-NAME). alpha-Methyl-5-HT showed the same potency as that of 5-HT, indicating the involvement of the 5-HT(2) receptor. (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane (DOI), 5-methoxytryptamine and 1-(3-chlorophenyl)piperazine hydrochloride (mCPP) were potent, and 2-methyl-5-HT, 5-carboxamidotryptamine, BW723C86 and 6-chloro-2-(1-piperazinyl)pyrazine hydrochloride (MK212) were moderate, but (+/-)-8-hydroxy-2-dipropylaminotetralin hydrobromide (8-OH-DPAT), [endo-N-8-methyl-8-azabicyclo-(3,2,1)oct-3-yl]-2,3-dihydro-(1-methyl)ethyl-2-oxo-1H-benzimidazol-1-carboxamide (BIMU-8) and cisapride were weak agonists. Correlation of pEC(50) values of these agonists with documented pEC(50) values for 5-HT(2C) receptor was higher than 5-HT(2A) and 5-HT(2B). Cinanserin, ketanserin, methiothepin, methysergide, mianserin, (8-[5-(2,4-dimethoxy-5-(4-trifluoromethylphenylsulphonamido)phenyl-5-oxopentyl)-1,3,8-triazaspiro[4,5]decane-2,4-dione hydrochloride (RS102221), N-(1-methyl-1H-indolyl-5-yl)-N'-(3-methyl-5-isothiazolyl)urea (SB204741), spiperone and N-desmethylclozapine concentration-dependently inhibited the contractile responses to 5-HT. Correlation of pK(b)/pA(2) of antagonists with documented pK(i) for 5-HT(2C) receptor was highest among 5-HT(2) receptor subtypes. In the methysergide- and ketanserin-treated proventriculus, 5-HT, 2-methyl-5-HT and cisapride did not enhance the electrical field stimulation (5 Hz)-induced cholinergic contractions. 5-HT applied non-cumulatively caused transient contraction of ileum, and the responses were partly decreased by atropine or tetrodotoxin. 5-Methoxytryptamine, alpha-methyl-5-HT, 5-carboxamidotryptamine, L692,247 and DOI were potent agonists. However, 2-methyl-5-HT, cisapride, BW723C86, 8-OH-DPAT and 5-nonyloxytryptamine, mCPP and MK212 were less effective. Ketanserin and methysergide decreased the 5-HT-induced ileal contraction, but neither GR113808 nor SB269970 inhibited the responses. In conclusion, 5-HT causes contraction of the proventriculus via 5-HT(2C)-like receptors present on smooth muscle. 5-HT also causes contraction of the ileum, but the underlying mechanisms are complex, involving neural and smooth muscle components, and both 5-HT(1)- and 5-HT(2)-like receptors. Neural 5-HT receptors similar to 5-HT(3)/5-HT(4) receptors were not found in the chicken proventriculus and ileum.
Are the inflammatory bowel diseases autoimmune disorders? (1990)

Are the inflammatory bowel diseases autoimmune disorders?